Genomed Spolka Akcyjna Logo

Genomed Spolka Akcyjna

Biotechnology firm for genetic research and molecular diagnostics using NGS technology.

GEN | WAR

Overview

Corporate Details

ISIN(s):
PLGNOMD00024 (+3 more)
LEI:
259400MZZJNF1JFWAG26
Country:
Poland
Address:
Warszawa Ponczowa 12, 02-971 Warszawa

Description

Genomed Spolka Akcyjna is a biotechnology company specializing in genetic research and molecular diagnostics. It offers a comprehensive range of services centered on DNA and RNA sequencing, analysis, and synthesis, primarily utilizing Next Generation Sequencing (NGS) technology. The company's core activities include the analysis of gene sequences to identify mutations responsible for congenital diseases, with the capability to analyze thousands of genes. Genomed serves both the clinical diagnostics and research sectors, providing services to the medical and biotechnological markets. A key strategic focus is the development and introduction of genomic technologies into personalized medicine, aiming to advance genomic prevention and gene treatments in medical practice.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 18:18
Rekomendacja dotycząca podziału zysku Spółki za rok 2024 - Content (PL)
Polish 617 bytes
2024-04-15 14:45
Sprzedaż_G.Gromada
Polish 202.6 KB
2024-04-15 14:45
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 425 bytes
2024-04-12 13:38
Powiadomienie_Kupno-SPr
Polish 485.9 KB
2024-04-12 13:38
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 532 bytes
2024-01-05 12:08
Diagnostyka_Sprzedaż
Polish 5.2 KB
2024-01-05 12:08
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 414 bytes
2023-12-27 13:24
Diagnostyka_27DEC_2023
Polish 5.8 KB
2023-12-27 13:24
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 379 bytes
2023-12-27 11:10
ABC_23Dec2023
Polish 4.3 KB
2023-12-27 11:10
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 463 bytes
2023-12-21 16:20
Zgloszenie_Marek_Zagulski_23Dec_2023
Polish 4.3 KB
2023-12-21 16:20
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 416 bytes
2023-12-13 17:09
Diagnostyka_13Dec2023
Polish 5.5 KB
2023-12-13 17:09
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 409 bytes

Automate Your Workflow. Get a real-time feed of all Genomed Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomed Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomed Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CAMBRIDGE COGNITION HOLDINGS PLC Logo
Develops digital solutions and a platform for CNS clinical trials to assess brain health.
United Kingdom
COG
A clinical-stage biopharmaceutical company developing novel cancer therapeutics.
Japan
4575
Captor Therapeutics S.A. Logo
Develops Targeted Protein Degradation therapies for cancer and autoimmune diseases.
Poland
CTX
Cardiff Oncology, Inc. Logo
A clinical-stage biotech developing cancer therapies that inhibit Polo-like kinase 1.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
Develops AI-powered epigenetic and genetic tests for early heart disease detection.
United States of America
CDIO
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing treatments for Central Nervous System disorders.
United States of America
SAVA
Celcuity Inc. Logo
Clinical-stage biotech developing targeted therapies for multiple solid tumors.
United States of America
CELC
Develops and manufactures cellulose-based nonwoven fabrics for the cosmetics sector.
South Korea
318160
CEL SCI CORP Logo
Clinical-stage biotech developing immunotherapies for cancer and infectious diseases.
United States of America
CVM
Celyad Oncology SA Logo
Biotechnology company developing innovative CAR-T cell therapies to treat cancer.
Belgium
CYAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.